CRON
Cronos Group, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.25
+1.25%Margins
Gross margin
36.2%
EBITDA margin
5.0%
EBIT margin
5.6%
Net margin
31.0%
FCF margin
22.1%
6.5%
Return on equity
5.9%
Return on assets
1.2%
Return on invested capital
0.19x
Asset turnover
$60.1M
Cash from operations
$2.16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026